SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) has received U.S. Patent No. 7,771,716 (the ‘716 patent) for Celution® System based methods of treating musculoskeletal disorders such as spinal disc disease. The ‘716 patent covers the therapeutic use of adipose-derived stem and regenerative cells (ADRCs) for promoting repair and regeneration of the spinal disc and formation of bone, cartilage, skeletal muscle, tendon and ligaments.
